BLCM insider filings

BELLICUM PHARMACEUTICALS, INC — 46 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-24. Screen BLCM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for BLCM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — BELLICUM PHARMACEUTICALS, INC

FiledFormInsiderReported transactionsSource
2023-11-244BAKER BROS. ADVISORS LP — 10% owner
BAKER JULIAN — 10% owner
BAKER FELIX — 10% owner
Baker Bros. Advisors (GP) LLC — 10% owner
Option exercise/expiry (X): 174,742 @ $0.00 · Option exercise/expiry (X): 1,941,607 @ $0.00 · Option exercise/expiry (X): 174,742 (derivative) @ $0 · Option exercise/expiry (X): 1,941,607 (derivative) @ $0EDGAR
2023-01-204/AHuber Reid M — DirectorOption exercise (M): 80,968 @ $0EDGAR
2023-01-054Daly James M — DirectorOption exercise (M): 60,414 @ $0EDGAR
2023-01-054Huber Reid M — DirectorOption exercise (M): 87,196 @ $0EDGAR
2023-01-054Stonehouse Jon P — DirectorOption exercise (M): 121,452 @ $0EDGAR
2023-01-054Klimovsky Judith V — DirectorOption exercise (M): 60,414 @ $0EDGAR
2023-01-054DAVIS STEPHEN — DirectorOption exercise (M): 74,739 @ $0EDGAR
2023-01-044/AStonehouse Jon P — DirectorOption exercise (M): 60,580 @ $0EDGAR
2022-09-024Klimovsky Judith V — DirectorOption exercise (M): 35,082 @ $0EDGAR
2022-09-024Daly James M — DirectorOption exercise (M): 35,082 @ $0EDGAR
2022-09-024Huber Reid M — DirectorOption exercise (M): 46,489 @ $0EDGAR
2022-09-024Stonehouse Jon P — DirectorOption exercise (M): 60,580 @ $0EDGAR
2022-09-024DAVIS STEPHEN — DirectorOption exercise (M): 43,400 @ $0EDGAR
2022-09-014/AStonehouse Jon P — DirectorOption exercise (M): 21,054 @ $0 · Option exercise (M): 21,054 (derivative) @ $0EDGAR
2022-08-164Scripture Charity — Chief Development OfficerGrant/award (A): 250,000 (derivative) @ $1.44EDGAR
2022-08-164Fair Richard A. — President and CEO, DirectorGrant/award (A): 400,000 (derivative) @ $1.44EDGAR
2022-06-164Stonehouse Jon P — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-164Klimovsky Judith V — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-164Daly James M — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-164Huber Reid M — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-164DAVIS STEPHEN — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2022-01-064Huber Reid M — DirectorOption exercise (M): 19,494 @ $0 · Option exercise (M): 19,494 (derivative) @ $0EDGAR
2022-01-064BROWN JAMES F — DirectorOption exercise (M): 28,384 @ $0 · Option exercise (M): 28,384 (derivative) @ $0EDGAR
2022-01-064Stonehouse Jon P — DirectorOption exercise (M): 21,504 @ $0 · Option exercise (M): 21,504 (derivative) @ $0EDGAR
2022-01-064Daly James M — DirectorOption exercise (M): 13,568 @ $0 · Option exercise (M): 809 @ $0 · Option exercise (M): 13,568 (derivative) @ $0 · Option exercise (M): 809 (derivative) @ $0EDGAR
2022-01-064Klimovsky Judith V — DirectorOption exercise (M): 14,036 @ $0 · Option exercise (M): 566 @ $0 · Option exercise (M): 14,036 (derivative) @ $0 · Option exercise (M): 566 (derivative) @ $0EDGAR
2022-01-064DAVIS STEPHEN — DirectorOption exercise (M): 18,715 @ $0 · Option exercise (M): 18,715 (derivative) @ $0EDGAR
2021-12-024Scripture Charity — Chief Development OfficerGrant/award (A): 150,000 (derivative) @ $1.73EDGAR
2021-08-184/AFair Richard A. — President and CEO, DirectorGrant/award (A): 265,000 (derivative) @ $0EDGAR
2021-08-164Fair Richard A. — President and CEO, DirectorGrant/award (A): 265,000 (derivative) @ $0EDGAR
2021-07-074Stonehouse Jon P — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-074Klimovsky Judith V — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-074Huber Reid M — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-074Daly James M — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-074BROWN JAMES F — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-074DAVIS STEPHEN — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-064Klimovsky Judith V — DirectorGrant/award (A): 566 (derivative) @ $0EDGAR
2021-07-064Daly James M — DirectorGrant/award (A): 809 (derivative) @ $0EDGAR
2021-01-054Stonehouse Jon P — DirectorGrant/award (A): 21,054 (derivative) @ $0EDGAR
2021-01-054Klimovsky Judith V — DirectorGrant/award (A): 14,036 (derivative) @ $0EDGAR
2021-01-054Huber Reid M — DirectorGrant/award (A): 19,494 (derivative) @ $0EDGAR
2021-01-054BROWN JAMES F — DirectorGrant/award (A): 28,384 (derivative) @ $0EDGAR
2021-01-054Daly James M — DirectorGrant/award (A): 13,568 (derivative) @ $0EDGAR
2021-01-054DAVIS STEPHEN — DirectorGrant/award (A): 18,715 (derivative) @ $0EDGAR
2020-12-164Strauss David Eric — Sr Director, Corp ControllerGrant/award (A): 35,000 (derivative) @ $0EDGAR
2020-12-164Fair Richard A. — President and CEO, DirectorGrant/award (A): 286,000 (derivative) @ $0EDGAR

Recent 8-K events — BELLICUM PHARMACEUTICALS, INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-02-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-218-K2.01 — Completion of Acquisition or Disposition of Assets
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-248-K3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-228-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-218-K7.01 — Regulation FD DisclosureEDGAR
2023-06-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-05-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BLCM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs